Armata Pharmaceuticals Statistics

Total Valuation

ARMP has a market cap or net worth of $85.03 million. The enterprise value is $204.77 million.

Market Cap	85.03M
Enterprise Value	204.77M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

ARMP has 36.18 million shares outstanding. The number of shares has increased by 0.15% in one year.

Shares Outstanding	36.18M
Shares Change (YoY)	+0.15%
Shares Change (QoQ)	+61.24%
Owned by Insiders (%)	0.20%
Owned by Institutions (%)	3.89%
Float	11.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.82
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	55.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.25

Current Ratio	0.25
Quick Ratio	0.22
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.87

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-25.09%
Return on Capital (ROIC)	-28.04%
Revenue Per Employee	$56,348
Profits Per Employee	-$1.02M
Employee Count	66
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.30% in the last 52 weeks. The beta is 0.80, so ARMP's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	+8.30%
50-Day Moving Average	2.34
200-Day Moving Average	2.89
Relative Strength Index (RSI)	50.37
Average Volume (20 Days)	5,612

Short Selling Information

The latest short interest is 5,937, so 0.02% of the outstanding shares have been sold short.

Short Interest	5,937
Short Previous Month	5,340
Short % of Shares Out	0.02%
Short % of Float	0.05%
Short Ratio (days to cover)	1.08

Income Statement

In the last 12 months, ARMP had revenue of $3.72 million and -$67.04 million in losses. Loss per share was -$2.14.

Revenue	3.72M
Gross Profit	-28.68M
Operating Income	-42.06M
Pretax Income	-79.58M
Net Income	-67.04M
EBITDA	-40.91M
EBIT	-42.06M
Loss Per Share	-$2.14

Full Income Statement

Balance Sheet

The company has $26.41 million in cash and $146.14 million in debt, giving a net cash position of -$119.74 million or -$3.31 per share.

Cash & Cash Equivalents	26.41M
Total Debt	146.14M
Net Cash	-119.74M
Net Cash Per Share	-$3.31
Equity (Book Value)	-46.10M
Book Value Per Share	-1.28
Working Capital	-92.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$38.55 million and capital expenditures -$7.53 million, giving a free cash flow of -$46.08 million.

Operating Cash Flow	-38.55M
Capital Expenditures	-7.53M
Free Cash Flow	-46.08M
FCF Per Share	-$1.27

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,130.87%
Pretax Margin	-1,802.72%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-996.19%

Dividends & Yields

ARMP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.15%
Shareholder Yield	-0.15%
Earnings Yield	-78.85%
FCF Yield	-54.19%

Analyst Forecast

The average price target for ARMP is $7.00, which is 197.87% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	197.87%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	66.19%
EPS Growth Forecast (5Y)	-45.53%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ARMP has an Altman Z-Score of -6.06 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.06
Piotroski F-Score	1